Containing Or Obtained From Narcissus (e.g., Daffodil, Sabidilla, Etc.) Patents (Class 424/753)
-
Patent number: 10939686Abstract: The present invention is directed to methods of controlling pathogenic fungi comprising applying sabadilla oil.Type: GrantFiled: April 10, 2018Date of Patent: March 9, 2021Assignee: McLaughlin Gormley King CompanyInventors: Robert A. Suranyi, Darrick David Unger
-
Patent number: 10743547Abstract: The invention relates to methods for preparing a concentrated sabadilla extract and to methods of its use as a pesticide.Type: GrantFiled: October 18, 2018Date of Patent: August 18, 2020Assignee: McLaughlin Gormley King CompanyInventors: Dain Andrews Thompson, John Thomas Bergman, Darrick David Unger
-
Patent number: 10743545Abstract: The invention relates to methods for controlling pests by application of sabadilla oil to pests' environment or to pests. This present invention is also directed to methods for producing sabadilla oil by removing the oil from plants.Type: GrantFiled: October 18, 2018Date of Patent: August 18, 2020Assignee: McLaughlin Gormley King CompanyInventors: John Thomas Bergman, Darrick David Unger, Robert A. Suranyi
-
Patent number: 10743546Abstract: The invention relates to methods for preparing a dry, flowable sabadilla extract and to methods of its use as a pesticide.Type: GrantFiled: October 18, 2018Date of Patent: August 18, 2020Assignee: McLaughlin Gormley King CompanyInventors: John Thomas Bergman, Darrick David Unger
-
Patent number: 10646461Abstract: A pharmacological composition for the treatment of bacterial and protozoal infections in a patient. The preferred pharmacological composition comprises a pharmaceutical carrier and an active composition selected from the group consisting of: a) an amount of sodium oxalate and an amount of oxalic acid, b) an amount of sodium citrate and an amount of citric acid, or c) mixtures of a) and b). The amounts and weight ratios of a) the sodium oxalate and oxalic acid, and b) the sodium citrate and citric acid in the active composition are such as to produce a safe and effective pharmacological composition. Sodium salts of other carboxylic acids may be used. The invention also relates to the method of using the pharmacological composition for the safe and effective treatment of bacterial infections, protozoal infections and dermatological diseases.Type: GrantFiled: November 19, 2019Date of Patent: May 12, 2020Inventor: Naeem Uddin
-
Patent number: 10159251Abstract: The present invention is directed to pesticidal mixtures comprising sabadilla alkaloids and azadirachtin and methods of controlling pests including insects and mites by application of pesticidal mixtures comprising sabadilla alkaloids and azadirachtin.Type: GrantFiled: June 29, 2017Date of Patent: December 25, 2018Assignee: MCLAUGHLIN GORMLEY KING COMPANYInventors: Robert A. Suranyi, Donald L. Sundquist
-
Patent number: 10143204Abstract: The invention relates to methods for preparing a concentrated sabadilla extract and to methods of its use as a pesticide.Type: GrantFiled: October 21, 2016Date of Patent: December 4, 2018Assignee: MCLAUGHLIN GORMLEY KING COMPANYInventors: Dain Andrews Thompson, John Thomas Bergman, Darrick David Unger
-
Patent number: 10136651Abstract: The present invention is directed to methods of producing de-oiled sabadilla extract by removing the oil from sabadilla seeds or a sabadilla extract. The invention also relates to methods for controlling pests by application of de-oiled sabadilla extract to pests' or to their environment.Type: GrantFiled: October 21, 2016Date of Patent: November 27, 2018Assignee: MCLAUGHLIN GORMLEY KING COMPANYInventors: John Thomas Bergman, Darrick David Unger
-
Patent number: 10130102Abstract: The invention relates to methods for preparing a dry, flowable sabadilla extract and to methods of its use as a pesticide.Type: GrantFiled: October 21, 2016Date of Patent: November 20, 2018Assignee: MCLAUGHLIN GORMLEY KING COMPANYInventors: John Thomas Bergman, Darrick David Unger
-
Patent number: 9034401Abstract: The present disclosure describes pharmaceutical compositions and methods for reducing duration, intensity, and/or bothersomeness of common colds in humans and for reducing severity or duration of common cold symptoms such as nasal congestion, runny nose, watery eyes, dry/scratchy throat and sneezing in humans exhibiting such symptoms. The compositions herein comprise extracts of at least one of Luffa Operculata (L. operculata), S. officinale (V. sabadilla), and Galphimia Glauca (G. glauca) in a pharmaceutically acceptable carrier, and in various embodiments, comprise a mixture of all three Luffa Operculata (L. operculata) 10% extract MT, S. officinale (V. sabadilla) 3× extract, and Galphimia Glauca (G. glauca) 10% extract MT in a pharmaceutically acceptable carrier.Type: GrantFiled: July 9, 2014Date of Patent: May 19, 2015Assignee: MATRIXX INITIATIVES, INC.Inventors: Timothy L. Clarot, Arlene M. Ascarate
-
Publication number: 20110052731Abstract: The present invention relates to an extract of a processed herbal medicinal plant and a composition for skin external application which contains the extract. More specifically, the composition for skin external application contains an extract of processed herbal medicinal plant, prepared through a method comprising the steps of: (a) processing an herbal medicinal plant by a process of boiling, steaming, roasting, baking or heating the medicinal plant or a combination of two or more of these processes; (b) obtaining an extract of the processed medicinal plant. The composition shows an improved antioxidant effect.Type: ApplicationFiled: November 6, 2008Publication date: March 3, 2011Inventors: Jun Seong Park, Hye Yoon Park, Dong Hyun Kim, Eun Jeonag Moon, Ji Hye Chung, Jae Kyoung Lee, Duck Hee Kim, Han Kon Kim
-
Publication number: 20090246152Abstract: The invention relates to agents for sequestering serum aging factors, and methods for using the same. More particularly, the invention relates to agents termed herein “Naractin” to denote any one of several naturally-occurring arNOX inhibitors either present in N. tazetta powder or capable of augmenting N. tazetta powder to an inhibitory level comparable to that of the fresh N. tazetta extracts, and to methods for using “Naractins” to prevent or treat disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX). In one exemplary embodiment the agents of the invention comprise at least one naturally occurring Naractin. Such naturally occurring naractins are also capable of augmenting the anti-arNOX effect of other naturally occurring arNOX inhibitory agents.Type: ApplicationFiled: March 28, 2008Publication date: October 1, 2009Applicant: Nu Skin International, Inc.Inventors: Dale Kern, Christiaan Meadows
-
Publication number: 20090246153Abstract: A composition and method having anti-aging properties is provided. The composition comprises an arNOX inhibitory agent present in a natural plant extract and is useful topically as a cosmetic. The symptoms of aging including lines, wrinkles, hyperpigmentation, dehydration, loss of elasticity, angioma, dryness, itching, telangietasias, actinic purpura, seborrheic keratoses and actinic keratoses. The invention may be used multiple times a day without deleterious effects.Type: ApplicationFiled: March 28, 2008Publication date: October 1, 2009Applicant: Nu Skin International, Inc.Inventor: Dale Kern
-
Publication number: 20070280898Abstract: Embodiments of the present disclosure include a dermatological composition for the treatment of skin blemishes, more particularly for the treatment of scars and/or stretch marks. The dermatological composition can include 0.1-1.0 parts by weight of bulbus allium (onion) powder, 0.5-5.0 parts by weight of the obroma cacao (cocoa) seed butter, 0.1-2.0 parts by weight of butyrospermum parkii (shea butter), 0.1-3.0 parts by weight of tocopherol acetate, 0.01-0.05 parts by weight of allantoin, 1.0-5.0 parts by weight of punica granatum (pomegranate) seed oil, 1.0-5.0 parts by weight of persea gratissima (avocado) oil, 1.0-5.0 parts by weight of canibis sativa (hemp) seek oil, 0.1-0.25 parts by weight of a preservative, dermatologically-acceptable aqueous carrier 70-75 parts by weight, fragrance optional, for a total of 100 parts by weight, in the form of a cream.Type: ApplicationFiled: June 6, 2006Publication date: December 6, 2007Inventor: Sheri L. Riddle
-
Patent number: 7052708Abstract: The invention is an animal repellant composition containing one or more toxins, including for example one or more alkaloids isolated from for example, one or more members of the family Narcissus, and optionally containing one or more polymers, including for example one or more bioerodible polymers and/or more non-absorbable polymers. The animal repellant composition is useful for repelling animals from vegetation and for rendering vegetation unpalatable to animals. The invention also includes methods for repelling animals, as well as methods for treating vegetation to render the vegetation unpalatable to animals, such animals including for example, deer, voles, moles, ground hogs, mice, rats, rodents, raccoons, nematodes, larvae, worms, fungi, molds, bacteria, vegetative organisms, and insects. A suberin-polymer-repellant chemical complex and a method for treating damaged vegetation are also disclosed.Type: GrantFiled: January 16, 2004Date of Patent: May 30, 2006Assignee: The Corato FoundationInventor: Robert O'Leary
-
Patent number: 6926901Abstract: The invention is an animal repellant composition containing one or more plant derived toxins, including for example one or more alkaloids isolated from for example, one or more members of the family Narcissus, and optionally containing one or more polymers, including for example one or more bioerodible polymers and/or more non-absorbable polymers. The animal repellant composition is useful for repelling animals from vegetation and for rendering vegetation unpalatable to animals. The invention also includes methods for repelling animals, as well as methods for treating vegetation to render the vegetation unpalatable to animals, such animals including for example, deer, voles, moles, ground hogs, mice, rats, rodents, raccoons, nematodes, larvae, worms, fungi, molds, bacteria, vegetative organisms, and insects. A suberin-polymer-repellant chemical complex and a method for treating damaged vegetation are also disclosed.Type: GrantFiled: April 22, 2003Date of Patent: August 9, 2005Assignee: The Corato FoundationInventor: Robert K. O'Leary
-
Publication number: 20040202638Abstract: The invention provides cosmetics or dermatological compositions comprising plant extract or whey extract having an action to potentiate laminin 5 productivity in the epidermal cells. They have mainly the action and efficacy to prevent or improve aging in the skin.Type: ApplicationFiled: February 20, 2004Publication date: October 14, 2004Inventors: Keiko Takada, Satoshi Amano, Toshio Nishiyama
-
Publication number: 20040156920Abstract: Novel oil extracts from Angiosperm and Gymnosperm plants and other-plant biomass from human, veterinary, birds, aquatic species, microbial and mycological sources useful in human, veterinary and agricultural, mycological and microbiological applications are described. Methods of preparation of these extracts in oil and methods of application and administration are also described.Type: ApplicationFiled: January 7, 2003Publication date: August 12, 2004Inventor: Shantaram Govind Kane
-
Publication number: 20040151781Abstract: Pharmaceutical formulation, its use, and method for its manufacture The present invention relates to a pharmaceutical formulation of a calcium salt and a dry plant extract in the form of a coated tablet, wherein it has a core of at least one dry plant extract, enveloped by at least one coating of at least one calcium salt. The plant extracts for the core may be selected from: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard lily); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (purple trefoil); Oenothera biennis hom. (primrose); Glycine soja (soy bean); Serenoa repens (saw-palmetto); Urtica dioica (stinging nettle), in particular its root; Cucurbita pepo (pumpkin), in particular its seed; Pygeum africanum; as well as suitable mixtures of these.Type: ApplicationFiled: December 8, 2003Publication date: August 5, 2004Inventor: Michael A Popp
-
Publication number: 20040052870Abstract: The present invention is directed toward a method for inhibiting COX-2 in an organism. In particular, the method is preferably directed toward selectively inhibiting COX-2 in an organism. The method comprises the step of administering to the organism an organic extract isolated from an edible plant wherein such extract inhibits COX-2 A method to purify a composition that exhibits COX-2 inhibition and COX-2 selective inhibition from the organic extract is also provided. In addition, a method for treating and/or preventing COX-2 mediated inflammation or inflammation-associated disorders in an organism is provided.Type: ApplicationFiled: September 30, 2003Publication date: March 18, 2004Inventors: Mark G. Obukowicz, Susan L. Hummert
-
Publication number: 20040047924Abstract: A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation.Type: ApplicationFiled: June 20, 2003Publication date: March 11, 2004Applicant: I.B.R. Israeli Biotechnology Research Ltd.Inventors: Etienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry
-
Patent number: 6635287Abstract: A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation.Type: GrantFiled: July 27, 2001Date of Patent: October 21, 2003Assignee: I.B.R. Israeli Biotechnology Research Ltd.Inventors: Etienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry
-
Publication number: 20030118673Abstract: The invention discloses the use of smilagenin and anzurogenin D in the treatment of cognitive dysfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.Type: ApplicationFiled: January 3, 2003Publication date: June 26, 2003Inventors: Zongqin Xia, Yaer Hu, Ian Rubin, Jonathan Brostoff, Brian Whittle, Weijun Wang, Phil Gunning
-
Patent number: 6565867Abstract: The invention is an animal repellant composition containing one or more plant derived toxins, including for example one or more alkaloids isolated from for example, one or more members of the family Narcissus, and optionally containing one or more polymers, including for example one or more bioerodible polymers and/or one or more non-absorbable polymers. The animal repellant composition is useful for repelling animals from vegetation and for rendering vegetation unpalatable to animals. The invention also includes methods for repelling animals, as well as methods for treating vegetation to render the vegetation unpalatable to animals, such animals including for example, deer, voles, moles, ground hogs, mice, rats, rodents, racoons, nematodes, larvae, worms, fungi, molds, bacteria, vegetative organisms, and insects.Type: GrantFiled: December 12, 2000Date of Patent: May 20, 2003Assignee: The Corato FoundationInventor: Robert K. O'Leary
-
Publication number: 20030082119Abstract: The invention relates to a cosmetic compact or cream powder which is provided with self-tanning agent and optionally light-protecting characteristics. The dihydroxy acetone (DHA) portion of said powder is fully used for coloration. The cosmetic powder contains a self-tanning agent selected from mixtures of DHA and aqueous mahakanni extract and mixtures of DHA with mahakanni and tulips extract, additional chromophore pigments, a wax or a mixture of several waxes, a powder basis and optionally additional cosmetic auxiliaries and active agents in stable homogeneous distribution. The inventive powder is produced by mixing the powder basis and a first portion of the pigments with the molten wax. The self-tanning agent and a second portion of the pigments in an aqueous-alcoholic suspension having a pH value ranging from 3-4 are subsequently added into the molten was mixture at 65 to 70° C. The entire mixture is steered, homogenised and cooled.Type: ApplicationFiled: September 20, 2002Publication date: May 1, 2003Inventors: Karin Golz-Berner, Leonhard Zastrow
-
Publication number: 20030012831Abstract: The subject matter of the present invention concerns a process for the isolation of the alkaloid galanthamine; the galanthamine itself which has been produced according to this process; the use of the galanthamine thus produced in galenic preparations; and the galanthamine thus produced for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.Type: ApplicationFiled: September 12, 2002Publication date: January 16, 2003Inventors: Thomas Hille, Hans-Rainer Hoffmann, Mirko Kreh, Rudolf Matusch
-
Publication number: 20030012796Abstract: An herbal composition comprised of extracts from the following herbs: Garlic (Allium Sativum), Onion (Allium Cepa), Cat Claw (Macfadyena Unguis-cati), Rat Root (Chicocca Alba), Pear Leaf (Persea Americana), Billyweb Bark (Sweetia Panamensis), Strongback (Desmodium Abscendens), Aloe (Aloe Barbadensis), Life Leaf (Bryophyllum Pinnatum), Sarsaparilla (Smilax Officinalis), Bamboo (Aralia Mubicaulis), Geritout (Pluchea Symphytofolia), Hibiscus (Hibiscus Rosa-sinensis), Balsam (Myroxylon Balsamum). The composition acts as a tonic to improve respiration, aid in the elimination of toxins and improves overall vitality.Type: ApplicationFiled: July 10, 2001Publication date: January 16, 2003Inventor: Alvin Foster Rigby
-
Publication number: 20020197338Abstract: Disclosed are botanical compositions, and more particularly to compositions having particularly beneficial therapeutic or prophylactic properties in a mammal. In particular, the compositions of the present inventions are useful inter alia in the treatment and/or prophylaxis of obesity, overeating, and other eating disorders, as well as an oral supplement in place of, or commensurate with, the consumption of food. The compositions of the present invention may be conveniently formulated for suitable administration, such as, for example, as a dried composition. In particularly preferred embodiments, the compositions of the present invention encompass formulations that comprise, consist essentially of, or consist of, a plurality of at least three herbal plants, horticultural and/or botanical equivalents, and/or extracts thereof, having similar or equivalent medicinal or therapeutic properties.Type: ApplicationFiled: June 6, 2001Publication date: December 26, 2002Inventors: Albert Peng Sheng Tseng, Yoland Sim Huat Lim, Hai Ping Sun
-
Publication number: 20020071878Abstract: A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation.Type: ApplicationFiled: July 27, 2001Publication date: June 13, 2002Applicant: I.B.R. Israeli Biotechnology Research Ltd.Inventors: Etienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry
-
Patent number: 6342254Abstract: A dormant preparation (DC) is provided which is capable of inhibiting proliferation of various kinds of cells. The preparation comprises an extract which is obtained from cells or tissue originating in an organism capable of entering a phase of dormancy in at least one of its parts and comprises at least one substance which induces or maintains the state of dormancy in the organism from which the cells or tissue are derived. The DC may be used for a variety of indications including human medicine and cosmetics, plant growth control and food preservation. A preferred dormant preparation is prepared from a water extract of Narcissus (daffodil) bulb.Type: GrantFiled: November 29, 1999Date of Patent: January 29, 2002Assignee: I.B.R. Israeli Biotechnology Research, Ltd.Inventors: Etienne Soudant, Lea Bezalel, Meira Ziv, Inon Perry